K-Phos No. 2
Generic: POTASSIUM PHOSPHATE, MONOBASIC AND SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS
Basic Information
Manufacturer
Beach Products, Inc.
Product Type
HUMAN PRESCRIPTION DRUG
Route of Administration
ORAL
FDA Set ID
9f446400-c403-4971-879e-1341f7f7d9da
Indications & Usage
INDICATONS AND USAGE K-PHOS® No.
2 is a highly effective urinary acidifier for use in patients with elevated urinary pH.
This product helps keep calcium soluble and reduces odor and rash caused by ammoniacal urine.
Also, by acidifying the urine, it increases the antibacterial activity of methenamine mandelate and methenamine hippurate.
2 is a highly effective urinary acidifier for use in patients with elevated urinary pH.
This product helps keep calcium soluble and reduces odor and rash caused by ammoniacal urine.
Also, by acidifying the urine, it increases the antibacterial activity of methenamine mandelate and methenamine hippurate.
Adverse Reactions
ADVERSE REACTIONS Gastrointestinal upset (diarrhea, nausea, stomach pain and vomiting) may occur with phosphate therapy.
Also, bone and joint pain (possible phosphate-induced osteomalacia) could occur.
The following adverse effects may be observed (primarily from sodium or potassium): headaches; dizziness; mental confusion; seizures; weakness or heaviness of legs; unusual tiredness or weakness; muscle cramps; numbness, tingling, pain, or weakness of hands or feet; numbness or tingling around lips; fast or irregular heartbeat; shortness of breath or troubled breathing; swelling of feet or lower legs; unusual weight gain; low urine output; unusual thirst.
Also, bone and joint pain (possible phosphate-induced osteomalacia) could occur.
The following adverse effects may be observed (primarily from sodium or potassium): headaches; dizziness; mental confusion; seizures; weakness or heaviness of legs; unusual tiredness or weakness; muscle cramps; numbness, tingling, pain, or weakness of hands or feet; numbness or tingling around lips; fast or irregular heartbeat; shortness of breath or troubled breathing; swelling of feet or lower legs; unusual weight gain; low urine output; unusual thirst.